Robot surgeons put to the test in major cancer operation study
NCT ID NCT05696444
Summary
This study is testing the safety and performance of Medtronic's new Hugo robotic surgery system for urologic procedures, primarily for cancers of the bladder, prostate, and kidney. It will enroll 144 adult patients needing specific cancer surgeries to see if the robot can complete operations without needing to switch to traditional methods. Researchers will track surgical success, complication rates, recovery times, and long-term cancer outcomes for up to five years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Duke Medical Center
Durham, North Carolina, 27710, United States
-
Mount Sinai
New York, New York, 10029, United States
-
Swedish Medical Center
Seattle, Washington, 98122, United States
-
University of Chiago
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.